AU5550498A - Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical compositionfor inhibiting one or more psychiatric disorders - Google Patents

Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical compositionfor inhibiting one or more psychiatric disorders

Info

Publication number
AU5550498A
AU5550498A AU55504/98A AU5550498A AU5550498A AU 5550498 A AU5550498 A AU 5550498A AU 55504/98 A AU55504/98 A AU 55504/98A AU 5550498 A AU5550498 A AU 5550498A AU 5550498 A AU5550498 A AU 5550498A
Authority
AU
Australia
Prior art keywords
inhibiting
manufacture
psychiatric disorders
compositionfor
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU55504/98A
Inventor
Birgitte Hjort Guldhammer
Erik Bardrum Nielsen
Birte Kloppenborg Skrumsager
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novo Nordisk AS
Original Assignee
Novo Nordisk AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk AS filed Critical Novo Nordisk AS
Publication of AU5550498A publication Critical patent/AU5550498A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU55504/98A 1997-01-29 1998-01-28 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical compositionfor inhibiting one or more psychiatric disorders Abandoned AU5550498A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK110/97 1997-01-29
DK11097 1997-01-29
PCT/DK1998/000033 WO1998032437A1 (en) 1997-01-29 1998-01-28 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more psychiatric disorders

Publications (1)

Publication Number Publication Date
AU5550498A true AU5550498A (en) 1998-08-18

Family

ID=8089855

Family Applications (1)

Application Number Title Priority Date Filing Date
AU55504/98A Abandoned AU5550498A (en) 1997-01-29 1998-01-28 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical compositionfor inhibiting one or more psychiatric disorders

Country Status (3)

Country Link
AU (1) AU5550498A (en)
WO (1) WO1998032437A1 (en)
ZA (1) ZA98682B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
WO2006032085A1 (en) 2004-09-21 2006-03-30 Novogen Research Pty Ltd Substituted chroman derivatives, medicaments and use in therapy
WO2012061413A2 (en) 2010-11-01 2012-05-10 Marshall Edwards, Inc. Isoflavonoid compositions and methods for the treatment of cancer
ES2877712T3 (en) 2015-02-02 2021-11-17 Mei Pharma Inc Combination therapies for use in the treatment of breast cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4328896A (en) * 1995-01-20 1996-08-07 Novo Nordisk A/S Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders

Also Published As

Publication number Publication date
ZA98682B (en) 1998-07-29
WO1998032437A1 (en) 1998-07-30

Similar Documents

Publication Publication Date Title
AU4098096A (en) 2,8-disubstituted quinazolinones
HK1025963A1 (en) Substituted 1,2,3,4-tetrahydronaphthalene derivatives
IL116746A0 (en) Use of 3, 4-diphenyl chromans for the preparation of pharmaceutical compositions
AU6222096A (en) Phenoxy piperazine derivatives for treating disorders of the dopamine system
AU1416195A (en) Substituted 1,2,3,4-tetrahydro-5-nitro pyrimidines
AU7447896A (en) Processes for the preparation of octafluoro-{2,2}paracyclophane
HK1032785A1 (en) Novel 3,6-hemiketals from the class of 9a-azalides
AU6123196A (en) N-aryl-1,2,4-triazolin-5-ones
AU2504495A (en) Curved-ray replacement dynamics
IL116828A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
IL116745A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
AU5550498A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical compositionfor inhibiting one or more psychiatric disorders
AU6780298A (en) Production of 1,3-diaminopentane by hydrogenation of 3-aminopentanenitrile
IL116826A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
AU5550398A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical compositionfor inhibiting senescence-associated motor impairment
AU5550298A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical compositionfor increasing libido in post-menopausal women
AU7570798A (en) Ionic halomethyl-1,3,5-triazine photoinitiators
AU6838498A (en) 6,6'-bis-(1-phosphanorbornadiene) diphosphines
HUP9800297A3 (en) Use of 3,4-diphenyl chromans for the manufacture of a vasodilatory pharmaceutical composition
IL116747A0 (en) Use of 3,4-diphenyl chromans for the preparation of pharmaceutical compositions
AUPP003297A0 (en) 4,5-diaryloxazole compounds
ZA976170B (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for lowering intraocular pressure.
AU2387597A (en) Process for the hydroxylation of 1,4-dichlorobenzene
AU9198698A (en) Process for the preparation of substituted 5,6-dihydro-2h-pyran-2-ones
AU3433797A (en) Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome